(Q33922997)

English

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

phase III clinical trial

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

object named as

Richard A Adams

1

0 references

author name string

Angela M Meade

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Matthew T Seymour

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Richard H Wilson

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Ayman Madi

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

David Fisher

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sarah L Kenny

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Edward Kay

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Elizabeth Hodgkinson

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Malcolm Pope

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Penny Rogers

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Harpreet Wasan

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Stephen Falk

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Simon Gollins

14

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Tamas Hickish

15

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Eric M Bessell

16

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

David Propper

17

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

M John Kennedy

18

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Richard Kaplan

19

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Timothy S Maughan

20

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

MRC COIN Trial Investigators

21

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

5 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

642-653

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

5 July 2018

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

5 July 2018

Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

5 July 2018

Intermittent therapy in the palliative treatment of metastatic colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

5 July 2018

Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

5 July 2018

Capecitabine as adjuvant treatment for stage III colon cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

5 July 2018

Intermittent androgen deprivation therapy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

5 July 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

5 July 2018

Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

5 July 2018

Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

29 October 2018

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

29 October 2018

Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

29 October 2018

OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

29 October 2018

Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

29 October 2018

Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3159416

29 October 2018

Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21641867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reintroduction of Oxaliplatin Is Associated With Improved Survival in Advanced Colorectal Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21641867

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S1470-2045(11)70102-4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33922997&oldid=1535397744"